
Collegium Pharmaceutical Investor Relations Material
Latest events

Q4 2024
Collegium Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Collegium Pharmaceutical Inc
Access all reports
Collegium Pharmaceutical Inc. is a specialty pharmaceutical company that focuses on developing and commercializing medications for the treatment of pain and related conditions. The company emphasizes the use of innovative drug delivery technologies to create products designed to address medical needs while minimizing potential risks associated with treatment. The company is headquartered in Stoughton, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Collegium Pharmaceutical Inc


Q2 2024
Collegium Pharmaceutical Inc


Q4 2024
Collegium Pharmaceutical Inc
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
COLL
Country
🇺🇸 United States